Compounds > n-(2-pyridone-6-yl)-n--n--di-n-propylformamidine

n-(2-pyridone-6-yl)-n--n--di-n-propylformamidine and Parkinson-Disease

n-(2-pyridone-6-yl)-n--n--di-n-propylformamidine has been researched along with Parkinson-Disease* in 1 studies

Other Studies

1 other study(ies) available for n-(2-pyridone-6-yl)-n--n--di-n-propylformamidine and Parkinson-Disease

ArticleYear
Catechol O-methyltransferase: characterization of the protein, its gene, and the preclinical pharmacology of COMT inhibitors.
    Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

    Topics: Amidines; Animals; Antiparkinson Agents; Benzophenones; Brain; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Enzyme Inhibitors; Female; Levodopa; Macaca mulatta; Motor Activity; Nitriles; Nitrophenols; Parkinson Disease; Pregnancy; Pyridones; Rats; Tolcapone

1998